Enorama Pharma AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Bengt Jönsson, was filed 09 Sept 2025.
Enorama Pharma AB: what insiders have been doing
We have very little insider data for Enorama Pharma AB so far: the most recent filing dates from 23 December 2025. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
7
Thresholds
n/a
Buy Volume
€795,981
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleBengt Jönsson1 buy
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.99
Analyst consensus
Income statement
RevenueSEK 2.7M
Gross profit-SEK 15M-549% margin
EBITDA-SEK 73.5M-2683% margin
Net income-SEK 75.1M-2743.3% margin
Valuation
Beta1.83
Balance sheet & cash
Market capSEK 74M
Free Cash Flow-SEK 59.3M
Profitability & ownership
ROA-213.3%
% insiders91.1%
% institutions1.5%
Last declaration on 23 December 2025
Declarations7 total
- 125,000 shares0AktieISIN SE0008216329FI:A003V025-1
- 3,811,481 shares@ SEK 2.30100.0% of flowBTA (betald tecknad aktie)ISIN SE0021629151FI:A003S139-1Canonical exit: 7 Dec 2025 (T+90)
- 394,230 shares0TeckningsrättISIN SE0011870302FI:csv-6e9a9eb067a54720a9ef
- 98,070 shares0TeckningsrättISIN SE0011870302FI:csv-b18c94aac13e5e373d05
- 1,700,580 shares0TeckningsrättISIN SE0011870302FI:csv-e954e8f883800f9748cf
- 197,115 shares0TeckningsrättISIN SE0011870302FI:csv-837389eadebd509ce6a9
- 98,070 shares0TeckningsrättISIN SE0011870302FI:csv-944a5492dd33f5d8ed23
7 of 7 declarations
About Enorama Pharma AB
Enorama Pharma AB is a company focused on developing innovative pharmaceutical products, particularly in the field of addiction treatments. It is listed on the Stockholm Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
